Daiwa Securities Group
EW icon

Daiwa Securities Group’s Edwards Lifesciences EW Stock Holding History

Daiwa Securities Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
146,358
+5,385
+4% +$451K 0.03% 337
2026
Q1 		$11.3M Buy
140,973
+4,512
+3% +$372K 0.03% 305
2025
Q4 		$11.6M Buy
136,461
+3,616
+3% +$297K 0.04% 279
2025
Q3 		$10.3M Sell
132,845
-7,089
-5% -$554K 0.03% 284
2025
Q2 		$10.9M Buy
139,934
+24,475
+21% +$1.83M 0.04% 266
2025
Q1 		$8.37M Buy
115,459
+18,488
+19% +$1.32M 0.04% 277
2024
Q4 		$7.18M Buy
96,971
+6,849
+8% +$479K 0.03% 310
2024
Q3 		$5.95M Buy
90,122
+1,374
+2% +$99.8K 0.03% 338
2024
Q2 		$8.2M Buy
88,748
+14,768
+20% +$1.31M 0.04% 234
2024
Q1 		$7.07M Buy
73,980
+7,410
+11% +$622K 0.04% 255
2023
Q4 		$5.08M Buy
66,570
+5,375
+9% +$374K 0.03% 298
2023
Q3 		$4.24M Buy
61,195
+6,040
+11% +$485K 0.03% 318
2023
Q2 		$5.2M Buy
55,155
+2,342
+4% +$204K 0.03% 267
2023
Q1 		$4.37M Buy
52,813
+4,494
+9% +$353K 0.03% 300
2022
Q4 		$3.6M Buy
48,319
+2,908
+6% +$224K 0.03% 336
2022
Q3 		$3.75M Buy
45,411
+1,181
+3% +$114K 0.03% 306
2022
Q2 		$4.21M Buy
44,230
+1,179
+3% +$122K 0.03% 284
2022
Q1 		$5.07M Buy
43,051
+1,999
+5% +$224K 0.03% 284
2021
Q4 		$5.32M Sell
41,052
-574
-1% -$67K 0.03% 274
2021
Q3 		$4.71M Buy
41,626
+3,279
+9% +$374K 0.03% 275
2021
Q2 		$3.97M Buy
38,347
+5,655
+17% +$533K 0.03% 296
2021
Q1 		$2.73M Buy
32,692
+21
+0.1% +$1.77K 0.02% 344
2020
Q4 		$2.98M Buy
32,671
+499
+2% +$41.4K 0.02% 305
2020
Q3 		$2.57M Buy
32,172
+21,971
+215% +$1.71M 0.02% 288
2020
Q2 		$1.92M Sell
10,201
-20,402
-67% -$1.45M 0.04% 241
2020
Q1 		$1.92M Buy
30,603
+2,595
+9% +$187K 0.02% 329
2019
Q4 		$2.18M Sell
28,008
-315
-1% -$24.6K 0.02% 337
2019
Q3 		$2.08M Buy
28,323
+2,364
+9% +$166K 0.02% 339
2019
Q2 		$1.6M Sell
25,959
-435
-2% -$26.3K 0.01% 388
2019
Q1 		$1.68M Buy
26,394
+390
+1% +$22.3K 0.01% 370
2018
Q4 		$1.33M Buy
26,004
+1,956
+8% +$99K 0.01% 387
2018
Q3 		$1.4M Buy
24,048
+1,890
+9% +$92.4K 0.01% 440
2018
Q2 		$1.07M Buy
22,158
+1,485
+7% +$69.3K 0.01% 481
2018
Q1 		$961K Buy
20,673
+1,716
+9% +$74.5K 0.01% 502
2017
Q4 		$712K Sell
18,957
-9,792
-34% -$359K 0.01% 551
2017
Q3 		$1.05M Sell
28,749
-51
-0.2% -$1.95K 0.01% 450
2017
Q2 		$1.14M Sell
28,800
-14,550
-34% -$531K 0.01% 422
2017
Q1 		$1.36M Sell
43,350
-8,400
-16% -$263K 0.01% 400
2016
Q4 		$1.62M Sell
51,750
-76,500
-60% -$2.48M 0.01% 316
2016
Q3 		$5.15M Buy
128,250
+6,000
+5% +$226K 0.03% 161
2016
Q2 		$4.06M Buy
122,250
+18,600
+18% +$636K 0.02% 193
2016
Q1 		$3.05M Buy
103,650
+39,750
+62% +$1.1M 0.02% 225
2015
Q4 		$1.68M Buy
63,900
+19,500
+44% +$506K 0.01% 279
2015
Q3 		$1.05M Sell
44,400
-4,800
-10% -$116K 0.01% 359
2015
Q2 		$1.17M Buy
49,200
+6,000
+14% +$135K 0.01% 370
2015
Q1 		$1.03M Buy
43,200
+28,200
+188% +$633K 0.01% 328
2014
Q4 		$318K Sell
15,000
-1,200
-7% -$24.1K ﹤0.01% 516
2014
Q3 		$276K Sell
16,200
-2,400
-13% -$37.9K ﹤0.01% 551
2014
Q2 		$266K Hold
18,600
– – ﹤0.01% 566
2014
Q1 		$230K Sell
18,600
-1,200
-6% -$13.8K ﹤0.01% 603
2013
Q4 		$217K Hold
19,800
– – ﹤0.01% 627
2013
Q3 		$230K Sell
19,800
-1,200
-6% -$14K ﹤0.01% 604
2013
Q2 		$235K Buy
+21,000
New +$249K ﹤0.01% 609

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Daiwa Securities Group's EW Position: Q2 2026 in Review

Daiwa Securities Group increased its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, buying an estimated $451K and bringing the position to 146,358 shares worth $13.2M. The position accounts for 0.03% of the portfolio, ranked #337.

Daiwa Securities Group first reported a position in EW in Q2 2013 and has held it in 53 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Daiwa Securities Group held 146,358 shares of Edwards Lifesciences worth $13.2M as of Q2 2026.
  • Daiwa Securities Group bought 5,385 Edwards Lifesciences shares in Q2 2026, an estimated $451K.
  • Edwards Lifesciences made up 0.03% of Daiwa Securities Group's portfolio in Q2 2026, its #337 holding.
  • Daiwa Securities Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.